HER2 based subtyping of metastatic breast cancer: clinical and molecular characteristics

Senologie(2023)

Cited 0|Views11
No score
Abstract
Zielsetzung The question of whether HER2-low constitutes a distinct breast cancer (BC) sub-entity with specific clinical and molecular features remains unresolved.
More
Translated text
Key words
metastatic breast cancer,her2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined